UNSPSC 51401600: Tranquilizers and antimanic and antianxiety amides

This classification denotes tranquilizers and antimanic and antianxiety drugs made from organic compounds containing the -CO-NH2 radical.

UNSPSC 51401600 Tranquilizers and antimanic and antianxiety amides is a Class code that encompasses pharmaceutical supply and distribution contracts, though recent state and local solicitations under this code span a broader scope including naloxone procurement, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals with over-the-counter products. State and local governments use this code to source controlled and non-controlled pharmaceutical inventory for health departments, emergency response programs, pharmacy benefit administration, and multi-agency cooperative purchasing. Issuing bodies range from county health departments (Seminole County, Florida) to state health and human services agencies (Texas HHS Commission) and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP, serving Minnesota and Oregon). The scope of work includes annual naloxone procurement with quarterly delivery cycles, exploratory market intelligence on direct pharmaceutical manufacturer contracting for state employee and retiree plans, and competitive pricing agreements for generic pharmaceuticals distributed through authorized wholesalers under cGMP and Drug Supply Chain Security Act compliance.

Recent activity spans Florida, Texas, and the Minnesota–Oregon cooperative. Seminole County, Florida posted IFB60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with an initial two-year term and one-year renewal option, response deadline July 26, 2023. The Texas HHS Commission issued RFI HHS0017013 in early April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program targeting self-insured employers and state agencies outside traditional pharmacy benefit manager arrangements. MMCAP, administered by the Minnesota Department of Administration, released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026; the contract is weighted 75 percent on price competitiveness, requires participation by at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, Morris & Dickson), and carries a 3 percent administrative fee with performance penalties of $200 to $1,500 per violation.